Ledger.Open graph →
SEC Form D · filed April 9, 2020

Lengo Therapeutics, Inc

Offering
$16.0M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Menlo Park, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Anna Chen · Menlo Park, CAExecRoger Ulrich, Ph.D · Menlo Park, CADirectorTracy Saxton, Ph.D · Menlo Park, CAExec · DirectorDaniel Estes, Ph.D · Menlo Park, CAExec · DirectorSteve Bailey · Menlo Park, CAExecBrendon C. Lundberg · Lake Oswego, ORExecSo C. On · New York, NYExecSoul Peter Ventures Management Ltd · New York, NYExec · DirectorChristopher Olsen · Columbus, OHDirectorDavid Laizerovich · New York, NYExec · DirectorJeff Reich, Md · Birmingham, ALExec · DirectorRobert Mannherz, Md · Birmingham, ALExecNancy Easley-Mack · Birmingham, ALExecLillian Carson · Birmingham, ALExec · DirectorEric George, Md · Birmingham, ALDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗